Back to results
US 2022/0089550 A1Published application
Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)-n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide
AssigneeNeomed Institute - Institut Neomed
InventorsJilong JIANG, Alan TSE
Life of this patent
Estimating the term…
Abstract
Crystalline Forms of a compound of Formula I are provided. Crystalline Form A is among the crystalline Forms identified. Form A has an X-ray powder diffraction (XRPD) pattern having characteristic peaks expressed in degrees 2Θ (±0.2° 2Θ) at 3.07, 5.96, 11.89 and 17.85, and a Differential Scanning Calorimetry (DSC) thermogram that exhibits an endotherm having a peak temperature of about 168.9° C.
Claims94
A compound of Formula I:
- which is crystalline and exhibits an X-ray powder diffraction (XRPD) pattern having characteristic peaks expressed in degrees 2Θ (±0.2° 2Θ) at 3.07, 5.96, 11.89, and 17.85.
A compound of Formula I:
- which is crystalline and has a Differential Scanning Calorimetry (DSC) thermogram that exhibits an endotherm having a peak temperature of about 168.9° C.
A compound of Formula I:
- having an X-ray powder diffraction pattern substantially the same as shown in FIG. 1.
Dependencies are inferred from the claim text.